Roche’s Elecsys IL-6 test to support early detection of resp
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Given the growing need to manage respiratory failure, Roche’s Elecsys IL-6 test measures levels of the biomarker interleukin 6 (IL-6) in the human body and can be used to help identify patients who could be at high risk of development of severe respiratory illness.

The levels of IL-6 also helps identify patients who might be at high risk of disease progression.

Hospitals and laboratories can run the Elecsys IL-6 test on Roche’s Cobas e analyzers which are available in around 500 cities across India.

These fully automated systems can provide test results in approximately 18 minutes, with a test throughput of up to 300 tests/hour, depending on the analyzer.

Dr. Sandeep Sewlikar, Medical and Scientific Affairs Head, Roche Diagnostics India, said, “Responding to the need to address patient management relating to increasing cases of respiratory distress, I believe that our IL-6 biomarker plays the role of early indicator for acute inflammation in the management of critically ill patients.”

Source: https://www.healthissuesindia.com/2020/06/26/roche-diagnostics-indias-elecsys-il-6-test-to-help-identify-high-risk-of-severe-inflammatory-response/
Dr. A●●●●a A●●●●●●r and 3 others like this1 share
Like
Comment
Share